Palmitoylethanolamide and PPAR-α: The Molecular Switch Behind Its Anti-Inflammatory Action
Learn how PEA activates the PPAR-α nuclear receptor to reduce inflammation and pain: what the science shows and what it means for supplementation.
PEA Powder vs Capsules: Bioavailability, Cost, and Convenience Compared
Compare palmitoylethanolamide powder vs capsules across bioavailability, particle size, daily cost, and practical convenience.
PEA (Palmitoylethanolamide) Negative Reviews: What Users Actually Report
A grounded review of PEA supplement complaints, from GI discomfort and fatigue to skin reactions and real user cost/effectiveness feedback.
PEA for Osteoarthritis: Joint Pain Support Without the Long-Term Risks of NSAIDs
How palmitoylethanolamide (PEA) may support knee osteoarthritis pain without NSAID risks: mechanism, clinical evidence, and honest caveats.
Palmitoylethanolamide for Neuropathic Pain: A Review of Human Randomized Controlled Trials
An evidence-based review of human RCTs on palmitoylethanolamide (PEA) for neuropathic pain: mechanism, clinical findings, formulations, and safety.
Palmitoylethanolamide and Multiple Sclerosis: What the Evidence Shows About Neuroinflammation and Neuropathic Pain
PEA is an endogenous fatty acid amide studied for neuroinflammation and pain in multiple sclerosis. Here is what current evidence shows.
PEA for Migraine and Chronic Headache: What the Early Clinical Research Shows
Palmitoylethanolamide (PEA) is being studied for migraine prevention. Here’s an honest look at the proposed mechanism and early clinical findings.
Palmitoylethanolamide, Mast Cells, and Neuroinflammation: The Cellular Science Behind the Signal
Explore how PEA stabilizes mast cells and modulates neuroinflammatory signaling through PPAR-α activation and the ALIA mechanism. Informational, not medical adv
Palmitoylethanolamide (PEA) for Long COVID: Neuroinflammation, Brain Fog, and Post-Viral Pain
Explore the clinical evidence on palmitoylethanolamide (PEA) for long COVID symptoms including brain fog, olfactory loss, fatigue, and post-viral pain.
Palmitoylethanolamide (PEA) for IBS and Visceral Pain: Mast Cell Stabilization in the Gut
Explore how PEA may reduce IBS gut pain through mast cell stabilization and PPAR-α activation. Evidence-based overview with cited research.
PEA for Fibromyalgia: What Clinical Trials Actually Show
A review of clinical trial evidence on palmitoylethanolamide (PEA) for fibromyalgia pain, sleep, and disability, with honest caveats on what we know so far.
Palmitoylethanolamide (PEA) for Endometriosis Pain: A Review of Emerging Clinical Evidence
Can PEA reduce pelvic and menstrual pain in endometriosis? We review clinical trials on palmitoylethanolamide endometriosis pain, mechanisms, and evidence limit